Cardiac Pharmacology: Difference between revisions

Jump to navigation Jump to search
no edit summary
No edit summary
No edit summary
Line 328: Line 328:
!Side Effects (Prevalence %)
!Side Effects (Prevalence %)
|-
|-
|colspan="5" bgcolor="#E6E6FA"|'''Drug Category: ''Anti-hypertensives'''''
!colspan="5"|Anti-hypertensives
|-
|-
|rowspan="2"|Diuretics
|rowspan="2"|Diuretics
Line 405: Line 405:
|Nifedipine: 5-20mg 3 times daily
|Nifedipine: 5-20mg 3 times daily
|-
|-
|colspan="5" bgcolor="#E6E6FA"|'''Drug Category: ''Anti-Arrhythmics'''''
!colspan="5"|Anti-Arrhythmics
|-
|-
|Class I (sodium channel blockers)
|Class I (sodium channel blockers)
Line 440: Line 440:
|62.5-125 µg daily
|62.5-125 µg daily
|-
|-
|colspan="5" bgcolor="#E6E6FA"|'''Drug Category: ''Anti-platelet Drugs'''''
!colspan="5"|Anti-platelet Drugs
|-
|-
|rowspan="7"|
|rowspan="7"|
Line 472: Line 472:
|Dyspnoea (13.8%), haemorrhage, bruising; nausea (4.3%), vomiting, diarrhoea (3.7%), hypertension (3.8%), hypotension (3.2%), back pain (3.6%), abdominal pain, dyspepsia, gastritis, dizziness (4.5%), chest pain (3.7%), headache (6.5%), cough (4.9%), rash, pruritus, fatigue (3.2%),  constipation, arrhythmias including atrial fibrillation (4.2%), paraesthesia, confusion, hyperuricaemia, raised serum creatinine (7.4%), vertigo.<cite>Esc37</cite><cite>Esc38</cite>
|Dyspnoea (13.8%), haemorrhage, bruising; nausea (4.3%), vomiting, diarrhoea (3.7%), hypertension (3.8%), hypotension (3.2%), back pain (3.6%), abdominal pain, dyspepsia, gastritis, dizziness (4.5%), chest pain (3.7%), headache (6.5%), cough (4.9%), rash, pruritus, fatigue (3.2%),  constipation, arrhythmias including atrial fibrillation (4.2%), paraesthesia, confusion, hyperuricaemia, raised serum creatinine (7.4%), vertigo.<cite>Esc37</cite><cite>Esc38</cite>
|-
|-
|colspan="5" bgcolor="#E6E6FA"|'''Drug Category: ''Vitamin K Antagonists'''''
!colspan="5"|Vitamin K Antagonists
|-
|-
|
|
Line 486: Line 486:
|valign="top"|Haemorrhage, nausea, vomiting, diarrhoea, jaundice, hepatic dysfunction, pancreatitis, pyrexia, alopecia, purpura, rash, ‘purple toes’, skin necrosis (increased risk in patients with protein C or protein S deficiency)
|valign="top"|Haemorrhage, nausea, vomiting, diarrhoea, jaundice, hepatic dysfunction, pancreatitis, pyrexia, alopecia, purpura, rash, ‘purple toes’, skin necrosis (increased risk in patients with protein C or protein S deficiency)
|-
|-
|colspan="5" bgcolor="#E6E6FA"|'''Drug Category: ''Lipid-Lowering Drugs'''''
!colspan="5"|Lipid-Lowering Drugs
|-
|-
|rowspan="3"|Statins
|rowspan="3"|Statins
467

edits

Navigation menu